| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Richard Beasley | Q37838402 |
| Mark Weatherall | Q29643757 | ||
| P2093 | author name string | Holt S | |
| Masoli M | |||
| P2860 | cites work | Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate | Q34137816 |
| Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids | Q35563600 | ||
| Fluticasone propionate in asthma: a long term dose comparison study | Q35571425 | ||
| Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis | Q28345332 | ||
| Symptomatic adrenal insufficiency during inhaled corticosteroid treatment | Q28359843 | ||
| Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate | Q42777551 | ||
| Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial | Q43790288 | ||
| One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height | Q43819600 | ||
| Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate | Q43899130 | ||
| A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma | Q46354123 | ||
| Adrenal suppression secondary to inhaled fluticasone propionate | Q48142535 | ||
| Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma | Q48192371 | ||
| Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma | Q48231741 | ||
| Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate | Q48358923 | ||
| Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma | Q48423257 | ||
| Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids | Q48631511 | ||
| Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids | Q48631524 | ||
| Fluticasone propionate in children with moderate asthma | Q48907155 | ||
| Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. | Q50930065 | ||
| Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. | Q53328602 | ||
| Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide | Q57638496 | ||
| Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. | Q64907871 | ||
| Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states | Q70292161 | ||
| A placebo controlled trial of fluticasone propionate in asthmatic children | Q72564423 | ||
| Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma | Q73244325 | ||
| Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma | Q73255187 | ||
| Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma | Q73445017 | ||
| Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids | Q73483999 | ||
| Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma | Q73815299 | ||
| Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Fluticasone Propionate Study Group | Q74776596 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 902-907 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Archives of Disease in Childhood | Q4787296 |
| P1476 | title | Systematic review of the dose-response relation of inhaled fluticasone propionate | |
| P478 | volume | 89 |
| Q42205901 | Acute Adrenal Crisis in an Asthmatic Child Treated with Inhaled Fluticasone Proprionate |
| Q39783136 | Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone |
| Q37406595 | Comparison of inhaled corticosteroids: an update |
| Q36761823 | Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma |
| Q36831058 | Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations |
| Q46743117 | Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis |
| Q30393965 | International consensus on (ICON) pediatric asthma |
| Q80731559 | Management of asthma in children |
| Q38157770 | Pharmacotherapy of critical asthma syndrome: current and emerging therapies |
| Q36373455 | Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations |
| Q64096285 | Unmet needs in asthma |
| Q36600696 | Very high dose inhaled corticosteroids: panacea or poison? |
Search more.